Effect of quercetin on the transport of N-acetyl 5-aminosalicylic acid
Authors:
- 1 July 2013
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 65 (7) , 1037-1043
Abstract
Objectives: The aim of this study was to investigate the transporter-mediated transport of N-acetyl 5-aminosalicylic acid (Ac-5-ASA) and the effect of quercetin on Ac-5-ASA transport. Methods: Caco-2 cell monolayers grown in Transwells were used to study the transport of Ac-5-ASA in the absence or presence of quercetin, and apical-to-basolateral and basolateral-to-apical apparent permeability (PappAB and PappBA values, respectively) was determined. The effect of transporter inhibitors, such as MK571, quinidine and mitoxantrone, on the transport of Ac-5-ASA was investigated. Key findings: In the absence of transporter mediators, the transport of Ac-5-ASA was much higher in the basolateral-to-apical direction than in the opposite direction. The PappBA/PappAB ratio of Ac-5-ASA was 4.89. Quercetin inhibited the apical efflux of Ac-5-ASA and decreased the PappBA/PappAB ratio to 1.05. Of the transporter inhibitors, MK571 decreased the PappBA/PappAB ratio to 1.07; however, neither quinidine nor mitoxantrone had an effect on Ac-5-ASA transport. Conclusions: Ac-5-ASA was excreted by multidrug resistance-associated protein 2 from Caco-2 cells, and its transport was inhibited by quercetin. Our findings suggest that dose levels of sulfasalazine or 5-aminosalicylic acid can be decreased by coadministration of quercetin, leading to improved pharmaceutical care for inflammatory bowel diseases.Keywords
This publication has 31 references indexed in Scilit:
- N -Acetyltransferase 1 and 2 Genotypes Do Not Predict Response Or Toxicity To Treatment With Mesalamine and Sulfasalazine in Patients With Ulcerative ColitisAmerican Journal of Gastroenterology, 2002
- Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transportersCellular and Molecular Life Sciences, 2002
- Comparative Tolerability of Therapies for Ulcerative ColitisDrug Safety, 2002
- INTESTINAL FATE OF 5‐AMINOSALICYLIC ACID: REGIONAL AND SYSTEMIC KINETIC STUDIES IN RELATION TO INFLAMMATORY BOWEL DISEASEBasic & Clinical Pharmacology & Toxicology, 1997
- Delivery and fate of oral mesalamine microgranules within the human small intestineGastroenterology, 1995
- Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel diseaseGastroenterology, 1989
- Inhibition of prostaglandin synthetase in human rectal mucosa.Gut, 1983
- FACTORS ASSOCIATED WITH CARDIAC MORTALITY IN DEVELOPED COUNTRIES WITH PARTICULAR REFERENCE TO THE CONSUMPTION OF WINEThe Lancet, 1979
- Role of Prostaglandins in Ulcerative ColitisGastroenterology, 1978
- Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator PhenotypeNew England Journal of Medicine, 1973